Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Department of Dermatology, Venereology and Allergology, Psoriasis-Center, University Medical Center Schleswig-Holstein, Kiel, Germany.
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2202-2208. doi: 10.1111/jdv.15682. Epub 2019 Jul 8.
Even today, a substantial number of individuals with visible skin diseases still suffer from incomprehension and stigmatization. About 10 million people are affected by such diseases in Germany. The WHO strongly urges member states to take measures against stigmatization in skin diseases.
Objectives are the development of an action programme to raise awareness and address stigmatization. Therefore, conception, development and testing of interventions for the destigmatization of persons with skin diseases in Germany will be carried out.
A series of actions addressing decision makers, politicians and the Federal Ministry of Health were initiated, all based on the World Health Assembly (WHA). Argumentation was largely based on data from health services research. Supported by the Federal Ministry of Health, a concept against stigmatization was developed by an expert consortium of researchers, dermatologists and patients. Specific strategies of structured destigmatization between those affected and those not will be developed and scientifically evaluated.
The activities addressed to politics were - to a large extent - successfully and financially supported by a 3-year programme (2018-2020), designed to develop interventions against stigma. It was funded by the Federal Ministry of Health. The project includes conception and development, intervention and evaluation, data analyses and development of a long-term concept.
The WHO's call against stigmatization in psoriasis (resolution WHA67.9 and global report on psoriasis 2016) was taken into account and developed into a destigmatization programme supported by the German government and German politicians. This has been achieved by successful collaborations between dermatologists, researchers, patients and policymakers. Next step will be the testing of interventions in situations and surroundings, where stigmatization usually occurs. The data will be used for the implementation of a long-term concept that can be used to continue destigmatization in Germany far beyond the project's initial phase.
即便在今天,仍有大量患有可见性皮肤病的人群遭受误解和歧视。在德国,约有 1000 万人受此类疾病影响。世界卫生组织强烈敦促各成员国针对皮肤病患者的污名化问题采取措施。
旨在制定一项提高认识和消除污名化的行动计划。因此,将在德国开展针对皮肤病患者去污名化的干预措施的构思、开发和测试。
启动了一系列针对决策者、政治家和联邦卫生部的行动,这些行动均基于世界卫生大会(WHA)。论证主要基于卫生服务研究的数据。在联邦卫生部的支持下,一个由研究人员、皮肤科医生和患者组成的专家联盟制定了一项反污名化概念。将制定并科学评估针对受影响者和未受影响者的结构化去污名化策略。
针对政治的活动在很大程度上得到了一个为期 3 年(2018-2020 年)的项目的成功和资金支持,该项目旨在开发针对污名化的干预措施。该项目由联邦卫生部资助。该项目包括构思和开发、干预和评估、数据分析以及长期概念的制定。
世界卫生组织反对银屑病污名化的呼吁(WHA67.9 号决议和 2016 年全球银屑病报告)得到了考虑,并制定了一个由德国政府和德国政治家支持的去污名化计划。这是通过皮肤科医生、研究人员、患者和政策制定者之间的成功合作实现的。下一步将是在污名化通常发生的情况下和环境中测试干预措施。这些数据将用于实施一个长期概念,以便在该项目的初始阶段之后,在德国继续进行去污名化工作。